The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis

被引:50
作者
Udagawa, N [1 ]
机构
[1] Matsumoto Dent Univ, Dept Biochem, Shiojiri 3990781, Japan
关键词
RANKL; IL-17; IL-18; IFN-gamma; GM-CSF;
D O I
10.1007/s00774-003-0439-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoclasts, which are present only in bone, are multinucleated giant cells with the capacity to resorb mineralized tissues. These osteoclasts are derived from hemopoietic progenitors of the monocyte-macrophage lineage. Osteoblasts are involved in osteoclastogenesis through a mechanism involving cell-to-cell contact with osteoclast progenitors. The recent discovery of osteoclast differentiation factor (ODF)/ receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) allowed elucidation of the precise mechanism by which osteoblasts regulate osteoclastic bone resorption. Synovial fibroblasts and activated T lymphocytes from patients with rheumatoid arthritis also express RANKL, which appears to trigger bone destruction in rheumatoid arthritis as well. Recent studies have shown that T lymphocytes produce cytokines other than RANKL, such as interleukin (IL)-17, granulocyte macrophage-colony stimulating factor (GM-CSF) and interferon (IFN)-gamma, which have powerful regulatory effects on osteoclastogenesis. The possible roles of RANKL and other cytokines produced by T lymphocytes in osteoclast differentiation are described.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 56 条
[21]   Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand [J].
Kong, YY ;
Feïge, U ;
Sarosi, I ;
Bolon, B ;
Tafuri, A ;
Morony, S ;
Capparelli, C ;
Li, J ;
Elliott, R ;
McCabe, S ;
Wong, T ;
Campagnuolo, G ;
Moran, E ;
Bogoch, ER ;
Van, G ;
Nguyen, LT ;
Ohashi, PS ;
Lacey, DL ;
Fish, E ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 402 (6759) :304-309
[22]   OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis [J].
Kong, YY ;
Yoshida, H ;
Sarosi, I ;
Tan, HL ;
Timms, E ;
Capparelli, C ;
Morony, S ;
Oliveira-dos-Santos, AJ ;
Van, G ;
Itie, A ;
Khoo, W ;
Wakeham, A ;
Dunstan, CR ;
Lacey, DL ;
Mak, TW ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 397 (6717) :315-323
[23]   IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis [J].
Kotake, S ;
Udagawa, N ;
Takahashi, N ;
Matsuzaki, K ;
Itoh, K ;
Ishiyama, S ;
Saito, S ;
Inoue, K ;
Kamatani, N ;
Gillespie, MT ;
Martin, TJ ;
Suda, T .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1345-1352
[24]  
Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO
[25]  
2-#
[26]  
Kotake S, 1996, J BONE MINER RES, V11, P88
[27]   TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling [J].
Lomaga, MA ;
Yeh, WC ;
Sarosi, I ;
Duncan, GS ;
Furlonger, C ;
Ho, A ;
Morony, S ;
Capparelli, C ;
Van, G ;
Kaufman, S ;
van der Heiden, A ;
Itie, A ;
Wakeham, A ;
Khoo, W ;
Sasaki, T ;
Cao, ZD ;
Penninger, JM ;
Paige, CJ ;
Lacey, DL ;
Dunstan, CR ;
Boyle, WJ ;
Goeddel, DV ;
Mak, TW .
GENES & DEVELOPMENT, 1999, 13 (08) :1015-1024
[28]   IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion [J].
Lubberts, E ;
Joosten, LAB ;
Chabaud, M ;
van den Bersselaar, L ;
Oppers, B ;
Coenen-de Roo, CJJ ;
Richards, CD ;
Miossec, P ;
van den Berg, WB .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1697-1710
[29]   Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells [J].
Makiishi-Shimobayashi, C ;
Tsujimura, T ;
Iwasaki, T ;
Yamada, N ;
Sugihara, A ;
Okamura, H ;
Hayashi, S ;
Terada, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) :361-366
[30]   Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor [J].
Matsumoto, M ;
Sudo, T ;
Maruyama, M ;
Osada, H ;
Tsujimoto, M .
FEBS LETTERS, 2000, 486 (01) :23-28